MD News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

MD

Mkt Cap

$2.22B

Volume

407.20K

Next Earnings

November 2nd

Loading chart

MD

MDPediatrix Medical Group, Inc.

MD

Pay with—

Available Balance0.00

MD

Mkt Cap

$2.22B

Volume

407.20K

Next Earnings

November 2nd

Chart Financials Earnings News About Insider Filings

Why Pediatrix Medical Group (MD) is a Top Growth Stock for the Long-TermPediatrix Medical Group (MD) is highlighted as a potential growth stock with a #3 (Hold) Zacks Rank and an A VGM Score. The company shows strong growth prospects with forecasted year-over-year earnings growth of 13.7% for fiscal 2026, a B Growth Style Score, and a positive average earnings surprise of +17.4%. Two analysts revised earnings estimates higher in the last 60 days, with the consensus estimate increasing to $2.32 per share.Zacks Investment Research · Oct 9, 2026

Can Pediatrix Sustain Growth Despite Lower Patient Volumes?Pediatrix Medical Group (MD) reported 4% YoY revenue growth to $487.8 million in Q2 2026, driven by improved reimbursement and higher patient acuity, offsetting a 2.1% decline in patient volumes. The company reaffirmed its 2026 adjusted EBITDA guidance of $280-$300 million, though volume trends and easing collection benefits remain key risks.Zacks Investment Research · Sep 22, 2026

Cencora (COR) Up 3.8% Since Last Earnings Report: Can It Continue?Cencora reported Q3 fiscal 2026 adjusted EPS of $4.48, beating consensus estimates by 2.5%, with 12% year-over-year earnings growth. Revenue rose 5.1% to $84.76 billion but slightly missed expectations. The company raised its fiscal 2026 adjusted EPS guidance to $17.75-$17.95 and increased operating income growth outlook to 13-14%. However, post-earnings estimates have trended downward, and the stock received a Zacks Rank #3 (Hold) rating.Zacks Investment Research · Sep 4, 2026

Pediatrix Medical Group (MD) Up 3.4% Since Last Earnings Report: Can It Continue?Pediatrix Medical Group beat Q2 2026 earnings expectations with adjusted EPS of 63 cents (10.5% above consensus) and revenue of $487.8 million (2.2% above estimate), driven by improved cash collection and favorable payor mix. However, the company faced headwinds from lower patient volumes and higher operating costs. Management reaffirmed 2026 adjusted EBITDA guidance of $280-$300 million. The stock has gained 3.4% since the earnings report and carries a Zacks Rank #3 (Hold) rating with an overall VGM Score of A.Zacks Investment Research · Sep 3, 2026

ARS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights for neffy® (epinephrine nasal spray)ARS Pharmaceuticals reported $32.5 million in revenue for Q3 2025, primarily from neffy epinephrine nasal spray sales. The company continues to expand market presence through direct-to-consumer campaigns and has strong cash reserves of $288.2 million.GlobeNewswire Inc. · Nov 10, 2025

Pediatrix (MD) Q2 EPS Jumps 56%Pediatrix Medical Group reported strong Q2 2025 earnings, with non-GAAP EPS of $0.53 beating analyst expectations. Despite a 7.4% revenue decline due to practice divestitures, the company showed growth in hospital-based neonatal services and raised its adjusted EBITDA guidance.The Motley Fool · Aug 5, 2025

Midland et Probe Gold recommencent des travaux sur la découverte en cuivre-or-argent-molybdène sur l’option La PeltrieMONTRÉAL, 25 juin 2024 (GLOBE NEWSWIRE) -- Exploration Midland inc. (« Midland ») (TSX-V: MD), en partenariat avec Probe Gold Inc. (« Probe »), a le plaisir d’annoncer la reprise des travaux d’exploration sur la découverte d’un système minéralisé en cuivre-or-argent-molybdène (« Cu-Au-Ag-Mo ») effectuée en 2022 sur la propriété La Peltrie Option (« la Propriété »). Cet important système minéralisé est situé à 15 kilomètres au sud-est du gîte aurifère Zone 58N détenu par Agnico Eagle et à 25 kilomètres à l’ouest de l’ancienne mine Selbaie qui a produit 56,9 Mt titrant 0,87% Cu, 1,85% Zn, 39 g/t Ag et 0,55 g/t Au (production historique).GlobeNewswire Inc. · Jun 25, 2024

Midland and Probe Gold Resume Work on the Copper-Gold-Silver-Molybdenum Discovery on the La Peltrie OptionMONTREAL, June 25, 2024 (GLOBE NEWSWIRE) -- Midland Exploration Inc. (“Midland”) (TSX-V: MD), in partnership with Probe Gold Inc. (“Probe”), is pleased to announce that exploration work will resume on the copper-gold-silver-molybdenum (“Cu-Au-Ag-Mo”) discovery made in 2022 on the La Peltrie Option (the “Property”). This significant mineralized system is located 15 kilometres southeast of Agnico Eagle’s Zone 58N gold deposit and 25 kilometres west of the former Selbaie mine, which produced 56.9 Mt grading 0.87% Cu, 1.85% Zn, 39 g/t Ag, and 0.55 g/t Au (historical production).GlobeNewswire Inc. · Jun 25, 2024

Implied Volatility Surging for Pediatrix Medical (MD) Stock OptionsInvestors need to pay close attention to Pediatrix Medical (MD) stock based on the movements in the options market lately.Zacks Investment Research · Jun 7, 2024

Why Is Pediatrix Medical Group (MD) Down 15.9% Since Last Earnings Report?Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.Zacks Investment Research · Jun 6, 2024

to start trading

MD

MDPediatrix Medical Group, Inc.

MD

Pay with—

Available Balance0.00

Your PositionYou don't own any MD yet.

Related Tickers

Earnings